(1)
Sodium Dichloroacetate and 3-Bromopyruvate Induce Loss of Cell Viability and Metabolic Alterations in Melanoma and Breast Cancer Cells. RevSALUS 2022, 4 (Sup), 83. https://doi.org/10.51126/revsalus.v4iSup.306.